There are errors in the data presented in Tables 2 and 5. As a result, incorrect data values are also quoted in several places within the text of the manuscript.
In the last row of Table 2 on page 2041, “0.7 (0.0-6.0)” should be “6.5 (0-60).”
In lines 5 and 6 of the first full paragraph on page 2042, “median and 2-sided 95% CIs for the mean (standard deviation)” should read “mean (standard deviation) and 2-sided 95% CIs for the mean.”
Also, the data presented in Table 5 (page 2042) and Figure 3 (page 2043) are incorrect. The corrected Table 5 and Figure 3 are shown below. As a result of these errors, the mean von Willebrand factor (VWF):ristocetin cofactor activity (RCo) terminal half-life listed in the abstract on page 2038, “Results” on page 2043, and “Discussion” on page 2044 should be 22.6 hours (95% confidence interval [CI], 19.5-25.7) for recombinant VWF (rVWF) alone and 22.5 hours (95% CI, 17.4-27.6) for rVWF administered with recombinant factor VIII (rFVIII).
VWF:RCo of rVWF. Median, IQR, and range of VWF:RCo after infusion of 50 IU VWF:RCo/kg rVWF alone and together with rFVIII.
VWF:RCo of rVWF. Median, IQR, and range of VWF:RCo after infusion of 50 IU VWF:RCo/kg rVWF alone and together with rFVIII.
Under “PK” on page 2043, the ratio between the geometric mean AUC0-∞/dose of VWF:RCo for rVWF alone vs rVWF administered with rFVIII should be “1.02; 90% CI, 0.93-1.11.” In the same section, as well as in “Discussion” on page 2044, the incremental recovery (IR) should be 1.9 U/dL VWF:RCo/kg for rVWF with or without rFVIII.
These errors have been corrected in the online version of the article.
